Ironwood regains Nasdaq minimum bid price compliance after cure

IRONWOOD PHARMACEUTICALS INC

Received Nasdaq letter on Aug 29, 2025 confirming compliance with Bid Price Rule.
Previously disclosed non-compliance on May 28, 2025 for failing $1.00 minimum bid.
Cured by maintaining $1.00+ closing bid for 10 consecutive business days.
Matter is now closed; no further action required.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.